How does Nerlynx (neratinib) work?
Nerlynx (neratinib) is a type of targeted treatment that works by irreversibly binding to and inhibiting specific receptors on the surface of cancer cells called HER2, HER4, and EGFR receptors. These receptors receive signals that tell cancer to grow and spread. By inhibiting HER2 and EGFR receptors, Nerlynx prevents HER2 positive breast cancer cells from growing and multiplying.
Breast cancer affects up to one in eight women and one out of every four breast cancers are HER2 positive. HER2-positive breast cancers make too much of the HER2 protein and this type of breast cancer tends to be more aggressive and harder to treat than HER2 negative breast cancers. The HER2 protein sits on the surface of cancer cells and receives signals that tell cancer to grow and spread.
Nerlynx belongs to a category of medications called tyrosine kinase inhibitors. This drug works by irreversibly binding to and inhibiting HER2, HER4, and EGFR receptors, which are found in abnormally large quantities on cancer cells. This inhibits their activity, their ability to direct the activity of other cells, and tumor growth. Nerlynx may also be called an irreversible pan-HER inhibitor.
Nerlynx may be used for the treatment of early-stage HER2-positive breast cancer after treatment with trastuzumab has already been given. It may also be used in combination with capecitabine for adults with advanced or metastatic HER2-positive breast cancer who have already received two or more prior anti-HER2 based regimens.
References
- Nerlynx (neratinib) 04/2020 Puma Biotechnology, Inc. https://www.drugs.com/pro/nerlynx.html
- Nerlunx (neratinib) Nerlynx.com https://nerlynx.com/
- Nerlynx (neratinib) Breastcancer.org https://www.breastcancer.org/treatment/targeted_therapies/nerlynx#:~:text=Nerlynx%20is%20an%20irreversible%20pan,ability%20to%20receive%20growth%20signals
- Epidermal Growth Factor Receptor (HER1) Tyrosine Kinase Inhibitor ZD1839 (Iressa) Inhibits HER2/neu (erbB2)-overexpressing Breast Cancer Cells in Vitro and in Vivo. Cancer Research Dec 2001. https://cancerres.aacrjournals.org/content/61/24/8887#:~:text=The%20EGFR5%20(HER1%2C%20erbB1,family%20of%20transmembrane%20tyrosine%20kinases.&text=For%20HER2%2C%20the%20most%20common,%2Fneu%20locus%20(14)%20
Read next
Related medical questions
- Can you drink alcohol with Nerlynx?
- How long do you take Nerlynx for?
- Does Nerlynx cause hair loss?
- How do you take Nerlynx?
- What is the strongest chemotherapy drug for breast cancer?
- Why are my nipples sore? 7 possible causes
- How long do letrozole side effects last?
- What happens when you stop taking letrozole?
- Does anastrozole cause hair loss?
- How do you relieve joint pain associated with tamoxifen or Aromasin?
- What is the success rate of Keytruda?
- What are monoclonal antibodies?
- What does anastrozole do to your body?
- Is letrozole a form of chemotherapy?
- What is the lifetime or cumulative dose for Adriamycin?
- Does Femara make your hair fall out?
- What is Herceptin? Is Herceptin a chemo drug? How does it work?
- Why give Taxol (Paxel) before carboplatin?
- Does letrozole affect blood sugar levels?
- Will insurance pay for the cost of Ibrance?
- How does AC (Adriamycin and Cytoxan [cyclophosphamide]) work for Breast Cancer?
- What is the success rate for Femara in breast cancer?
- Why do you need to take Xeloda with food?
- Is it common to lose hair AFTER stopping tamoxifen?
- What are the long-term side effects of Adriamycin?
- Which is better - Aromasin or Femara?
- How long can you stay on Herceptin and Perjeta?
- How long do you take Verzenio for?
- How long does Herceptin stay in your body?
- How common is hair loss with Ibrance?
Drug information
Related support groups
- Neratinib (8 questions, 3 members)
- Nerlynx (8 questions, 4 members)
- Breast Cancer (121 questions, 304 members)